INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 419m ago
HOUSE PTR19m ago
SEC 13F19m ago
ROBINHOOD CHAIN18m ago
Corporate insider
PO

Pamir Ozan

Chief Financial OfficerCIK 0001834681

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells2 / 0
Max Insider Score41
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
41
PO
Pamir OzanChief Financial Officer
NAGENiagen Bioscience, Inc.
Open-market purchase
BUY$30K
4,465 sh
Nov 14, 2025Nov 17, 2025
traded Nov 14, 2025
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Niagen Bioscience, Inc.Chief Financial Officer · Nov 17, 2025
41
PO
Pamir OzanChief Financial Officer
NAGENiagen Bioscience, Inc.
Open-market purchase
BUY
$15K
2,220 sh
Nov 14, 2025
Nov 17, 2025
traded Nov 14, 2025
+3d
SEC FORM 4

Evidence